key: cord-0889928-ui8t41um authors: Grolmusz, Vince Kornél; Bozsik, Anikó; Papp, János; Patócs, Attila title: Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification date: 2021-03-08 journal: Front Immunol DOI: 10.3389/fimmu.2021.653489 sha: 2434adfa6f7213a0d7ecbe3b87c31a8799f55937 doc_id: 889928 cord_uid: ui8t41um The ongoing COVID-19 pandemic caused by the novel coronavirus, SARS-CoV-2 has affected all aspects of human society with a special focus on healthcare. Although older patients with preexisting chronic illnesses are more prone to develop severe complications, younger, healthy individuals might also exhibit serious manifestations. Previous studies directed to detect genetic susceptibility factors for earlier epidemics have provided evidence of certain protective variations. Following SARS-CoV-2 exposure, viral entry into cells followed by recognition and response by the innate immunity are key determinants of COVID-19 development. In the present review our aim was to conduct a thorough review of the literature on the role of single nucleotide polymorphisms (SNPs) as key agents affecting the viral entry of SARS-CoV-2 and innate immunity. Several SNPs within the scope of our approach were found to alter susceptibility to various bacterial and viral infections. Additionally, a multitude of studies confirmed genetic associations between the analyzed genes and autoimmune diseases, underlining the versatile immune consequences of these variants. Based on confirmed associations it is highly plausible that the SNPs affecting viral entry and innate immunity might confer altered susceptibility to SARS-CoV-2 infection and its complex clinical consequences. Anticipating several COVID-19 genomic susceptibility loci based on the ongoing genome wide association studies, our review also proposes that a well-established polygenic risk score would be able to clinically leverage the acquired knowledge. The ongoing COVID-19 pandemic caused by the novel coronavirus, SARS-CoV-2 has affected all aspects of human society with a special focus on healthcare. Although older patients with preexisting chronic illnesses are more prone to develop severe complications, younger, healthy individuals might also exhibit serious manifestations. Previous studies directed to detect genetic susceptibility factors for earlier epidemics have provided evidence of certain protective variations. Following SARS-CoV-2 exposure, viral entry into cells followed by recognition and response by the innate immunity are key determinants of COVID-19 development. In the present review our aim was to conduct a thorough review of the literature on the role of single nucleotide polymorphisms (SNPs) as key agents affecting the viral entry of SARS-CoV-2 and innate immunity. Several SNPs within the scope of our approach were found to alter susceptibility to various bacterial and viral infections. Additionally, a multitude of studies confirmed genetic associations between the analyzed genes and autoimmune diseases, underlining the versatile immune consequences of these variants. Based on confirmed associations it is highly plausible that the SNPs affecting viral entry and innate immunity might confer altered susceptibility to SARS-CoV-2 infection and its complex clinical consequences. Anticipating several COVID-19 genomic susceptibility loci based on the ongoing genome wide association studies, our review also proposes that a well-established polygenic risk score would be able to clinically leverage the acquired knowledge. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus responsible for the ongoing pandemic COVID-19 has yet infected more than 108 million people worldwide with a reported mortality rate between 0.5 and 10% in different countries (1) . SARS-CoV-2 is a novel coronavirus originally detected in China. The specific mechanism by which it infects humans and effects human health is not fully understood. The clinical characteristics of COVID-19 usually incorporates fever, fatigue, dry cough, and dyspnea, while severe infections may result in bilateral pneumonia, and life-threatening acute respiratory distress syndrome (ARDS). Although severe complications usually manifest in elder patients with concurrent chronic diseases (e.g., high blood pressure, diabetes) young, healthy individuals might also suffer from critical consequences of the disease, requiring intensive care. The wide range of disease susceptibility especially in younger patients suggests that difference in genetic background of individuals might contribute to these alterations. In fact, the analysis of previous, unrelated infectious diseases provides clear evidence that specific protective genetic variations are enriched in populations where certain infections are endemic. For instance, sickle cell trait and carrying specific HLA antigens in African populations confer diminished susceptibility against malaria infection (2, 3) . Another example, 32, a 32-base pair deletion of the CCR5 gene prevents cellular viral entry of human immunodeficiency virus (HIV) resulting in effective resistance against HIV infection in individuals homozygous regarding this variation (4) . In the present review we aim to summarize previously published genotype-phenotype studies of genes which might play a role in the susceptibility to COVID-19. The associations between various single nucleotide polymorphisms (SNPs) and certain traits were studied using targeted and genome-wide approaches. In the case of targeted approach, hypothesis-driven selection of specific genes/SNPs were analyzed in cases and controls while during genome-wide association studies (GWASs) detection of novel genomic loci with susceptibility to various traits/diseases are possible. Our examination focuses on genetic variants of 2 key processes in the initiation of the disease: viral entry and recognition and response by the innate immune system. Also, as several international collaborations are ongoing to provide large-scale genomic susceptibility data, we propose that a well-established polygenic risk score would be able to optimally leverage the acquired knowledge. Large emphasis has been directed to decipher how SARS-CoV-2 is incorporated in human cells. Key data in this regard originate from studies focusing on SARS-CoV, responsible for the SARS epidemic of 2002-2003, which shares 79.6% sequence identity with SARS-CoV-2 (5). In fact, the spike protein of SARS-CoV binds to angiotensin-converting enzyme 2 (ACE2) that serves as a receptor for the virus (6) , and recent data confirmed that SARS-CoV-2 also binds ACE2 in vitro (7) (8) (9) . Further analyses revealed that the spike protein of SARS-CoV-2 is cleaved by transmembrane protease serine 2 (TMPRSS2) (7) , facilitating viral entry. Also of note, both ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells (10) , elucidating the predilection of the lower airways. Additionally, proprotein convertase FURIN was shown to pre-activate the viral entry of SARS-CoV-2 (11), while additional factors as PIKfyve, TPCN2 and cathepsin L (CTSL) are also critical in this process (12) . Table 1 summarizes genetic variants of the aforementioned genes with suggested genotype-phenotype findings. The main physiological function of ACE2 is catalyzing the hydrolysis of angiotensin I and angiotensin II into angiotensin (1-9) and angiotensin (1-7), respectively, contributing to blood pressure regulation (34). Therefore, numerous SNP association studies were directed to ascertain the role of ACE2 genetic variants on certain cardiovascular and metabolic traits. Throughout several populations, ACE2 polymorphisms have been associated with susceptibility to cardiovascular and metabolic diseases including hypertension and type 2 diabetes mellitus underlining the potential functional impact of these SNPs on ACE2 expression and/or function (13) (14) (15) (16) (17) (18) (19) (20) (21) . A TMPRSS2 SNP has been linked to TMPRSS2-ERG genetic fusion which is a frequent molecular event in prostate cancer (22, 23). More importantly, a study examining patients of the 2009 swine flu pandemic caused by the H1N1 influenza virus found that TMPRSS2 SNP rs2070788 is associated with severity of the disease (24). Additionally, genotype-specific TMPRSS2 expression was confirmed in human lung tissues regarding rs2070788 and rs383510, the latter being tagged to the former polymorphism. Mechanistically, rs383510 was found to enhance the transcription of TMPRSS2 mRNA, and these 2 SNPs were also found to associate with susceptibility to the H7N9 influenza virus (24). Certain high throughput screening studies identified rs4702, a common genetic variant of proprotein convertase FURIN as susceptibility factor for schizophrenia and hypertension (25, 26), while other studies correlated another SNP rs17514846 with other various traits including coronary artery disease, metabolic syndrome and longevity (27-29). While we found no SNP association studies for PIKfyve, certain variants of the TPCN2 gene coding for cation-selective ion channel were found to be associated with type 2 diabetes mellitus (T2DM) and hair color (30, 31). In the case of CTSL, two studies performed on different populations confirmed that a promoter polymorphism correlates with hypertension in Asian and American populations (32, 33). After SARS-CoV-2 successfully infected cells, a complex immune response initiates, in which the rapid and coordinated response of the innate immunity is pre-requisite (35). Following infection, the innate immune system recognizes viral antigens mainly by RIG-I-Like Receptors (RLRs) and Toll-Like Receptors (TLRs) (35). In the first step in RLR-dependent immune response, cytoplasmic RNA sensors RIG-I and MDA5 recognize viral RNA, after which interaction with mitochondrial antiviral signaling protein (MAVS) initiate signaling changes activating interferon Frontiers in Immunology | www.frontiersin.org regulatory factor IRF3 and IRF7, resulting in type I IFN (IFN-α and IFN-β) production and antiviral response (35-38). Supplementary Table 1 summarizes the SNP association studies concerning the agents implicated in viral recognition and response by the innate immune system. Several RIG-I SNPs were found to be associated with neutralizing antibody levels after measles and rubella vaccinations while other studies found RIG-I SNPs to be associated with nasopharyngeal carcinoma and EV71-induced hand, foot, and mouth disease (39-43). MDA5 genetic variants were thoroughly investigated in relation to autoimmunity with several associations being found with psoriasis, systemic lupus erythematosus (SLE), type 1 diabetes mellitus (T1DM), hypothyroidism and multiple sclerosis (MS) (44-53). Polymorphisms in MAVS were analyzed regarding inflammatory response finding that rs7269320 associated with osteoarthritis (54). Moreover, in an African American cohort, where rs11905552 of the MAVS gene was much more frequent compared to European Americans, this SNP associated with low type I IFN production in patients with SLE (55). Studies focusing on genetic variants of IRF3 and IRF7 found associations with SLE and systemic sclerosis (56-59), while IFN-α genetic variants were found to be associated with mixed connective tissue disease and prognosis in glioma patients (60, 61). During TLR-mediated immune response, TLR3, TLR7, TLR8, and TLR9 sense intracellular, while TLR2 and TLR4 detect extracellular, cell surface-associated viral antigens (35, 62). TLRs transduce the signal by binding MyD88 and TRIF, which in turn stimulate IRF3, IRF7, and NF-κB enhancing type I IFN response (35, 63-65). A multitude of case-control studies analyzed the role of TLR-associated SNPs in health and disease. TLR3 SNPs were associated with infectious, autoimmune, and neoplastic diseases. Certain studies demonstrated association of TLR3 polymorphisms with hepatitis B and C virus (HBV and HCV), herpes simplex virus (HSV), HIV infections (66-72), while SNPs rs3775291, rs3775292, rs5743312, and rs7657186 were associated with vaccine-induced immunity to serogroup C meningococcal vaccine as defined by virus-specific IgG persistence (73) . rs3775291 was also associated with various autoimmune disorders including SLE, rheumatoid arthritis (RA), and sarcoidosis (74) (75) (76) . Regarding neoplastic diseases, TLR3 genetic variants were linked to breast, colorectal and nasopharyngeal cancers, while also serving as prognostic factors in colorectal cancer (CRC) and melanoma malignum (MM) (42, [77] [78] [79] [80] [81] . Several lines of evidence supported the association between SLE and TLR7 SNPs in various populations (82) (83) (84) (85) , while additional studies found correlation between TLR7 polymorphisms and susceptibility to HCV and chikungunya virus infection, asthma, and age-related macular degeneration (86) (87) (88) (89) . The association between rs3764880 of TLR8 and tuberculosis susceptibility in males has been confirmed in European, Russian, and Chinese populations (90) (91) (92) and other SNPs of TLR8 were associated with asthma, SLE, and chikungunya virus infection (84, 87, 88) . With regard to the fourth TLR sensing intracellular viral antigens, TLR9 has 4 SNPs which were found to be associated with several infectious, autoimmune, and neoplastic diseases. Confirmed associations with infectious diseases include malaria, cytomegalovirus (CMV), and tuberculosis (90, (93) (94) (95) (96) (97) , while individuals with certain TLR9 polymorphisms are more susceptible to post-infectious irritable bowel syndrome, SLE and lupus nephritis, Graves' disease-related ophthalmopathy, and RA (98) (99) (100) (101) (102) (103) (104) . With respect to neoplastic diseases, acute myeloid leukemia (AML), and cervical cancer were also associated with TLR9 genetic variants (105) (106) (107) , while rs187084 is proposed to be a prognostic factor in patients with prostate cancer (108) . TLR2 and TLR4 SNPs are probably the most widely investigated genetic variants in the scope of our review. Similarly to studies conducted in other TLR genes, TLR2 polymorphisms were also found to be associated with tuberculosis and CMV infection (90, (109) (110) (111) , and additional pathogenic role concerning bacterial vaginosis in HIV-infected patients, recurrent vulvovaginal candidiasis, aggressive periodontitis, neonatal sepsis, Lyme disease, pneumonia, and reactive arthritis were also proposed (112) (113) (114) (115) (116) (117) (118) (119) . SNP rs3804100 has been linked to measles-specific antibody levels following immunization, while rs5743708 associated with nasal Staphylococcus aureus carriage (120, 121) . Autoimmune disorders linked to TLR2 SNPs incorporate psoriasis and T1DM (122, 123) , while hepatocellular carcinoma (HCC), marginal zone lymphoma, oral, and laryngeal squamous cell carcinoma and prognosis of women with breast cancer have also been linked to certain genetic variants of TLR2 (124) (125) (126) (127) . TLR4 polymorphisms have been associated with various infectious diseases. Manifest tuberculosis is associated with rs11536889, rs12377632, rs1927911, and rs7873784 (109, 110, 128) , while additional associated infection-related diseases include sepsis and sepsis-related organ failure for rs11536889 and Chlamydia trachomatis infection in women with pelvic inflammatory disease for rs1927911 (129) (130) (131) . The most intensively investigated TLR4 SNP, rs4986790 is associated with a wide range of infections including Gram-negative and Mycobacterium bacteria in high-risk populations, severe respiratory syncytial virus disease, clinical malaria, recurrent cystitis, chronic cavitary pulmonary aspergillosis, HCV infection, and prognosis of HBV-infected individuals (132) (133) (134) (135) (136) (137) (138) (139) (140) (141) . It also has a probable effect on IL-4 secretion after measles vaccination (142) . Another SNP of TLR4, rs5030717 is associated with childhood otitis media (143) . With respect to autoimmune-related diseases, TLR4 SNPs associate with ankylosing spondylitis, RA, giant cell arteritis, and preeclampsia (144) (145) (146) (147) . In addition, rs10759932 and rs4986790 are linked to acute rejection following kidney and lung transplantation, respectively (148, 149) . Several TLR4 polymorphisms (rs10759932, rs10983755, rs11536889, rs1927911, rs2149356, and rs4986790) are associated with gastric cancer susceptibility, where the risk-elevating Helicobacter pylori infection might have an important role (150) (151) (152) (153) (154) . Other tumors linked to TLR4 genetic variants include HCC, prostate cancer, CRC, and non-Hodgkin lymphoma (NHL) (79, (155) (156) (157) (158) (159) (160) . Genetic variants of adapter molecule MYD88 are associated with tuberculosis susceptibility, Buerger disease and treatment response in patients with RA (90, (161) (162) (163) . SNPs of the other key adapter agent, TRIF are associated with pneumonia susceptibility and thyroid cancer (164, 165) . In addition to type I IFN response viral recognition in the innate immune system leads to NF-kB activation. NF-kB is a multiprotein complex consisting of NFKB1, NFKB2, RELA, RELB, and REL (166) . Type I IFN response and NF-kB activation result in IL-6 and IL-8 production (35). The activation of these mediators contributes to inflammation and complex antiviral immune response (35). As a key player in inflammatory response, NFKB1 genetic variants has also been associated with atherosclerotic manifestations including coronary artery disease, acute coronary syndrome, dilated cardiomyopathy, and ischaemic stroke (167) (168) (169) (170) (171) (172) (173) . Promoter polymorphism rs28362491 is linked to HCV infection and autoimmune diseases including Behcet's disease and SLE (174) (175) (176) , while rs3774937 is associated with acute rejection after renal transplantation (177) . Neoplastic diseases associated with NFKB1 SNPs include CRC, Hodgkin lymphoma, NHL, cervical squamous cell carcinoma, liver, thyroid, breast, and lung cancer (178) (179) (180) (181) (182) (183) (184) (185) (186) . rs11574851 of NFKB2 was found to be linked to RA susceptibility among anti-citrullinated protein antibodies-positive patients (187) , while in healthy women rs1049728 of RELA associated with the concentration of soluble ICAM-1, which is an endothelium-derived inflammatory marker (188) . Genetic variants of REL have been shown to be linked to various autoimmune diseases including RA, psoriasis, and celiac disease (189) (190) (191) (192) (193) . Polymorphisms of IL6 have been shown to pre-dispose to pulmonary tuberculosis, acute lung injury in patients with systemic inflammatory response syndrome and post-infectious irritable bowel syndrome (98, 194, 195 ). An association with RA has also been proposed (196) . rs1800795 has been shown to have a role in the prognosis of patients following renal and lung transplantation (197) (198) (199) . IL6 SNPs were also confirmed to have a role in the susceptibility of various cardiovascular disorders including hypertension and stroke (200) (201) (202) . IL-8 is coded by CXCL8 gene, SNPs of which have been shown to be linked to infectious, autoimmune, and neoplastic diseases. Acne vulgaris, chronic periodontitis, and invasive aspergillosis among immunocompromised patients have been shown to be associated with various variants (203) (204) (205) . Autoimmune diseases including idiopathic pulmonary fibrosis, childhood IgA nephropathy, erosive oral lichen planus, childhood asthma, and Graves' disease have also been linked to genetic variants of CXCL8 (206) (207) (208) (209) (210) . Concerning neoplastic diseases, non-small cell lung cancer, and gastric cancer have been proposed to be associated with CXCL8 SNPs (154, 211, 212) . In conclusion, large majority of the discussed SNPs present pleiotropic effects, among which the frequent presence of various autoimmune and infection-related traits highlights their putative involvement in the susceptibility and severity of COVID-19. As genetic susceptibility regarding COVID-19 is an ongoing topic of several large international collaborations we anticipate to acquire a large amount of evidence regarding susceptibility loci in the near future. Indeed, recent studies identified germline variants of TLR3-and IRF7-dependent type I IFN immunity to associate with more severe COVID-19 infection (213) . In particular, disease-causing germline variants have been detected in TLR3, UNC93B1, TICAM1, TBK1, IRF3, IRF7, IFNAR1, and IFNAR2 in patients with life-threatening COVID-19 (213) . Another recent study analyzing 1,610 COVID-19 patients and 2,205 control subjects from the first wave in heavily affected Italy and Spain found 2 chromosomal loci on chromosome three and nine with significant association with COVID-19 patients (214) . On chromosome three the affected area includes several actors which might alter COVID-19 susceptibility including chemokine receptors, while on chromosome nine the association signal coincided with the AB0 blood group locus (214) . AB0 blood group has independently been linked to COVID-19 susceptibility (214) (215) (216) . Further studies are needed to confirm these associations in independent populations. Applying this knowledge to detect individuals with elevated risk for severe disease might help to prioritize them for vaccination and stricter protection measures. As COVID-19 susceptibility and severity seem to have a polygenic background, we propose that a curated polygenic risk score (PGRS) might facilitate the detection of individuals with high risk for infection (Figure 1) . Based on genome-wide analyses, polygenic risk scores are able to detect high-risk individuals in various diseases, finetuning the more widely used risk stratification dependent on baseline anthropometric and physiological characteristics (217, 218) . A most recent GWAS on a cohort of COVID-19 patients from the U.K. found eight lead variants from independent genome-wide significant regions including rs2236757 in IFNAR2 coding for interferon α and β receptor subunit 2 (219). Though the individual odds ratio for each of the relatively frequent variants varies between 1.3 and 2.1, the combined odds ratio in the case of harboring all these susceptibility variants rises to 29.5, underlining the applicability of a polygenic risk score (219) . In addition to COVID-19 susceptibility, inclusion of genetic predictors of disease severity and treatment response might also be included. In particular, based on the effectiveness of glucocorticoid administration confirmed by the randomized, controlled RECOVERY clinical trial (220) , it would be interesting to see if pharmacogenetic modifiers of glucocorticoid action, sensitivity and metabolism contribute to the severity of COVID-19 infection and treatment response (221) . It is important to note that the majority of the observed associations in Table 1 and Supplementary Table 1 were only validated in specific populations. By analyzing the population-specific allelic frequencies of the reviewed viral entry and innate immunity-related SNPs reviewed (Supplementary Table 2 ) we can conclude that the large variations in SNP frequencies might heavily influence their association with various traits in select populations. Additionally, pronounced differences in risk allele frequencies of the 8 proposed lead COVID-19-related SNPs (219) are present in different populations (Supplementary Table 3) . Moreover, these differences most probably alter epistatic interactions between genes, adding an additional layer of complexity (222) . Therefore, the observed population dependency of genotypephenotype associations would probably result in populationspecific PGRSs rather than a universal PGRS optimal for all populations. Dedicated efforts to perform populationspecific GWASs regarding COVID-19 susceptibility and severity to build population-specific PGRSs are needed to address these differences. The disruption caused by the COVID-19 pandemic has yet unknown consequences on the whole human society and on each affected patient's health as well. Understanding the susceptibility toward this disease is important to detect high-risk individuals and also to decipher molecular mechanisms needed for the development of the clinical phenotype. Viral entry and innate immunity are key mechanisms in the initiation of SARS-CoV-2 infection. We performed a thorough literature review concerning genotype-phenotype association studies regarding agents of these mechanisms. Our results indicated that SNPs in the genes of these processes are frequently associated with susceptibility to various bacterial and viral infections. Additionally, several autoimmune diseases are also linked to these genes, underlining the versatile immune consequences of these genetic variants. Based on the confirmed associations it is highly plausible that the abovementioned SNPs might confer altered susceptibility to SARS-CoV-2 infection and its complex clinical consequences. In addition to viral entry and innate immunity, other mechanisms including adaptive immunity are also of paramount importance regarding the susceptibility to COVID-19 (35). To better characterize putative genomic susceptibility loci, well-designed, international genome-wide association studies (GWAS) are needed. As multiple GWASs on host genetic susceptibility are ongoing, several genomic susceptibility loci are proposed to be detected. Translating these individual susceptibility variants into clinically relevant polygenic risk scores would fully leverage this acquired knowledge to easily detect high-risk individuals prioritized for vaccination and stricter protective measures. All things considered, genetic variants of genes of viral entry and innate immunity might alter susceptibility, and prognosis of COVID-19. Further GWASs are needed to better characterize susceptibility loci and to develop clinically relevant risk stratification strategies. An interactive web-based dashboard to track COVID-19 in real time Polymorphism and natural selection in human populations Common west African HLA antigens are associated with protection from severe malaria Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection A pneumonia outbreak associated with a new coronavirus of probable bat origin Angiotensinconverting enzyme 2 is a functional receptor for the SARS coronavirus SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells Cell entry mechanisms of SARS-CoV-2 Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV Hypertension and hypertensive left ventricular hypertrophy are associated with ACE2 genetic polymorphism ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus Association of polymorphisms of angiotensin I converting enzyme 2 with retinopathy in type 2 diabetes mellitus among Chinese individuals Association of angiotensin-converting enzyme 2 gene polymorphism and enzymatic virus infection in Saudi Arabian patients Genetic polymorphisms in Toll-like receptor 3 gene are associated with the risk of hepatitis B virus-related liver diseases in a Chinese population Impaired tolllike receptor 3-mediated immune responses from macrophages of patients chronically infected with hepatitis C virus Association of toll-like receptor 3 single-nucleotide polymorphisms and hepatitis C virus infection Polymorphisms in Toll-like receptor 3 confer natural resistance to human herpes simplex virus type 2 infection A common polymorphism in TLR3 confers natural resistance to HIV-1 infection Association between TLR3 rs3775291 and resistance to HIV among highly exposed caucasian intravenous drug users Single nucleotide polymorphisms in the Toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine Polymorphisms within Toll-like receptors are associated with systemic lupus erythematosus in a cohort of Danish females A non-synonymous single-nucleotide polymorphism in the gene encoding toll-like receptor 3 (TLR3) is associated with sero-negative rheumatoid arthritis (RA) in a Danish population A tolllike receptor 3 single nucleotide polymorphism in Japanese patients with sarcoidosis IRAK4 and TLR3 sequence variants may alter breast cancer risk among African-American women Tolllike receptor 3−926T>A increased the risk of breast cancer through decreased transcriptional activity Toll-like receptor genes and their association with colon and rectal cancer development and prognosis TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression TLR7 single-nucleotide polymorphisms in the 3' untranslated region and intron 2 independently contribute to systemic lupus erythematosus in Japanese women: a case-control association study Sexspecific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus Single nucleotide polymorphisms in genes encoding toll-like receptors 7, 8 and 9 in Danish patients with systemic lupus erythematosus Toll-like receptor 7 gene single nucleotide polymorphisms and the risk for systemic lupus erythematosus: a case-control study Tolllike receptor 7 variations are associated with the susceptibility to HCV infection among Chinese females Association of toll-like receptor polymorphisms with susceptibility to chikungunya virus infection Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders Tolllike receptor polymorphisms and age-related macular degeneration Genetic variation in TLR pathway and the risk of pulmonary tuberculosis in a Moldavian population Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis Association of TLR8 and TLR9 polymorphisms with tuberculosis in a Chinese Han population: a case-control study Role of polymorphisms of toll-like receptor (TLR) 4, TLR9, toll-interleukin 1 receptor domain containing adaptor protein (TIRAP) and FCGR2A genes in malaria susceptibility and severity in Burundian children Toll-like receptor 9 (TLR9) polymorphism associated with symptomatic malaria: a cohort study TLR9-1486T/C and 2848C/T SNPs are associated with human cytomegalovirus infection in infants Association of TLR polymorphisms with development of tuberculosis in Indonesian females Variants in toll-like receptor 9 gene influence susceptibility to tuberculosis in a Mexican population Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis TLR7/8/9 polymorphisms and their associations in systemic lupus erythematosus patients from southern Brazil Association study of TLR-9 polymorphisms and systemic lupus erythematosus in northern Chinese Han population Association of toll-like receptor 9 gene polymorphism in Chinese patients with systemic lupus erythematosus in Taiwan Association of TLR9 gene polymorphisms with lupus nephritis in a Chinese Han population Tolllike receptor gene polymorphisms are associated with susceptibility to Graves' ophthalmopathy in Taiwan males The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients Variations in genes involved in regulation of the nuclear factor -kappaB pathway and the risk of acute myeloid leukaemia Involvement of Toll-like Receptor 9 polymorphism in cervical cancer development Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer Toll-like receptor signaling pathway variants and prostate cancer mortality The association analysis of TLR2 and TLR4 gene with tuberculosis in the Tibetan Chinese population Screening toll-like receptor markers to predict latent tuberculosis infection and subsequent tuberculosis disease in a Chinese population Polymorphisms in TLR-2 are associated with congenital cytomegalovirus (CMV) infection but not with congenital CMV disease Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents Toll-like receptor gene variants and bacterial vaginosis among HIV-1 infected and uninfected African women Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis Toll-like receptor 2 gene polymorphisms associated with aggressive periodontitis in Japanese Role of polymorphic variants as genetic modulators of infection in neonatal sepsis Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease Polymorphisms of dectin-1 and TLR2 predispose to invasive fungal disease in patients with acute myeloid leukemia Toll-like receptor 2 variants are associated with acute reactive arthritis The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity Relationship between toll-like receptor 2 R753Q and T16934A polymorphisms and Staphylococcus aureus nasal carriage TLR2 and TLR4 polymorphisms in Southern Chinese psoriasis vulgaris patients The polymorphism rs4696480 in the TLR2 gene is associated with psoriasis patients in the Turkish population The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma Toll-like receptor 2 rs4696480 polymorphism and risk of oral cancer and oral potentially malignant disorder Genetic predisposition of polymorphisms in HMGB1-related genes to breast cancer prognosis in Korean women Common polymorphisms in TLR4 gene associated with susceptibility to pulmonary tuberculosis in the Sudanese The association of polymorphisms of TLR4 and CD14 genes with susceptibility to sepsis in a Chinese population The regulatory toll-like receptor 4 genetic polymorphism rs11536889 is associated with renal, coagulation and hepatic organ failure in sepsis patients Variants in toll-like receptor 1 and 4 genes are associated with Chlamydia trachomatis among women with pelvic inflammatory disease Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections Tolllike receptor genetic variants are associated with Gram-negative infections in VLBW infants IL10RA, and NOD2 mutation in paediatric Crohn's disease patients: an association with Mycobacterium avium subspecies paratuberculosis and TLR4 and IL10RA expression Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease Investigation of host candidate malaria-associated risk/protective SNPs in a Brazilian amazonian population Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis The association of toll-like receptor 4 polymorphism with hepatitis C virus infection in Saudi Arabian patients Toll like receptor 4 D299G associates with disease progression in caucasian patients with chronic HBV infection: relationship with gender Toll-like receptor and hepatitis B virus clearance in chronic infected patients: a long-term prospective cohort study in Taiwan Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results Predisposition to childhood otitis media and genetic polymorphisms within the toll-like receptor 4 (TLR4) locus Genetically determined high activities of the TNF-alpha, IL23/IL17, and NFkB pathways were associated with increased risk of ankylosing spondylitis Association of TLR4 gene non-missense single nucleotide polymorphisms with rheumatoid arthritis in Chinese Han population Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis Maternal TLR4 and NOD2 gene variants, pro-inflammatory phenotype and susceptibility to early-onset preeclampsia and HELLP syndrome Impact of polymorphisms of TLR4/CD14 and TLR3 on acute rejection in kidney transplantation The role of innate immunity in acute allograft rejection after lung transplantation Genetic polymorphisms in the Toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer TLR4 polymorphisms associated with developing gastric pre-cancer lesions in a Chinese Han population Effect of the−2081G/A polymorphism of the TLR4 gene and its interaction with Helicobacter pylori infection on the risk of gastric cancer in Chinese individuals Polymorphisms of the TLR4 gene and risk of gastric cancer Profiles of gene polymorphisms in cytokines and Toll-like receptors with higher risk for gastric cancer A functional variant at miR-34a binding site in toll-like receptor 4 gene alters susceptibility to hepatocellular carcinoma in a Chinese Han population Toll-like receptor 4 genetic variation and advanced prostate cancer risk Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer Polymorphic variation of inflammation-related genes and risk of non-hodgkin lymphoma for Uygur and Han Chinese in Xinjiang The MyD88 rs6853 and TIRAP rs8177374 polymorphic sites are associated with resistance to human pulmonary tuberculosis A single nucleotide polymorphism in the 3'-untranslated region of MyD88 gene is associated with Buerger disease but not with takayasu arteritis in Japanese Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways Correlation between TICAM1 gene polymorphisms and community-acquired pneumonia in children Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population Proposed NF-kappa B/I kappa B family nomenclature Genetic Variation in NFKB1 and NFKBIA and susceptibility to coronary artery disease in a Chinese Uygur population Association between genetic polymorphism in NFKB1 and NFKBIA and coronary artery disease in a Chinese Han population Association of NF-kappaB1 gene polymorphisms with coronary artery disease in a Han Chinese population −94 ATTG insertion/deletion polymorphism of the NFKB1 gene is associated with coronary artery disease in Han and Uygur women in China NFKB1 gene rs28362491 polymorphism is associated with the susceptibility of acute coronary syndrome Functional polymorphism of the NFKB1 gene promoter is related to the risk of dilated cardiomyopathy The promoter polymorphism of NFKB1 gene contributes to susceptibility of ischemic stroke in Korean population Genetic variation on the NFKB1 genes associates with the outcomes of HCV infection among Chinese Han population Association of Pre-miRNA-499 rs3746444 and Pre-miRNA-146a rs2910164 polymorphisms and susceptibility to Behcet's disease NFKB1−94 insertion/deletion ATTG polymorphism contributes to risk of systemic lupus erythematosus Impact of NF-kappaB gene polymorphism on allograft outcome in hispanic renal transplant recipients The functional-94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes Polymorphic variation in NFKB1 and other aspirin-related genes and risk of hodgkin lymphoma Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of nonhodgkin's lymphoma Relationship between NFKB1−94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk Genetic polymorphism of NFKB1 and NFKBIA genes and liver cancer risk: a nested case-control study in A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases the risk of papillary thyroid carcinoma Gene combination of CD44 rs187116, CD133 rs2240688, NF-kappaB1 rs28362491 and GSTM1 deletion as a potential biomarker in risk prediction of breast cancer in lower Northern Thailand Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: results from the REPAIR consortium Genomewide association analysis of soluble ICAM-1 concentration reveals novel associations at the NFKBIK, PNPLA3, RELA, and SH2B3 loci REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis Confirmation of association of the REL locus with rheumatoid arthritis susceptibility in the UK population Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort An investigation of rheumatoid arthritis loci in patients with early-onset psoriasis validates association of the REL gene Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling Association of IL4, IL6, and IL10 polymorphisms with pulmonary tuberculosis in a Tibetan Chinese population Inflammation and immune-related candidate gene associations with acute lung injury susceptibility and severity: a validation study Association between interleukin-6 gene polymorphisms and rheumatoid arthritis in Chinese Han population: a case-control study and a meta-analysis IL-6 promoter polymorphism−174 is associated with newonset diabetes after transplantation Interleukin-6 and interferon-gamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation The interleukin-6−174promoter polymorphism is associated with long-term kidney allograft survival Association of interleukin-6 gene G-174C polymorphism and plasma plasminogen activator inhibitor-1 level in Chinese patients with and without hypertension Genetic polymorphisms and the risk of stroke after cardiac surgery Ischemic stroke risk, smoking, and the genetics of inflammation in a biracial population: the stroke prevention in young women study Polymorphism in the IL-8 gene promoter and the risk of acne vulgaris in a Pakistani population Haplotypes in the interleukin 8 gene and their association with chronic periodontitis susceptibility Polymorphisms in host immunity-modulating genes and risk of invasive aspergillosis: results from the AspBIOmics consortium A promoter SNP rs4073T>A in the common allele of the interleukin 8 gene is associated with the development of idiopathic pulmonary fibrosis via the IL-8 protein enhancing mode Polymorphisms of CXCL8 and its receptor CXCR2 contribute to the development and progression of childhood IgA nephropathy Association of interleukin-8 gene polymorphisms and haplotypes with oral lichen planus in a Chinese population IL-8 gene variants and expression in childhood Asthma Association studies of interleukin-8 gene in Graves' disease and Graves' ophthalmopathy Association of IL-8 gene polymorphisms with non small cell lung cancer in tunisia: a case control study IL-8-251T>A (rs4073) Polymorphism is associated with prognosis in gastric cancer patients Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Genomewide association study of severe Covid-19 with respiratory failure Relationship between the ABO blood group and the COVID-19 susceptibility Testing the association between blood type and COVID-19 infection, intubation, and death. medRxiv The personal and clinical utility of polygenic risk scores Towards clinical utility of polygenic risk scores Genetic mechanisms of critical illness in Covid-19 Dexamethasone in hospitalized patients with Covid-19 -preliminary report Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2 Epistasis-the essential role of gene interactions in the structure and evolution of genetic systems The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Copyright © 2021 Grolmusz, Bozsik, Papp and Patócs. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.